DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens of various pathogens as genetically engineered vaccines both preventive and ther...
Saved in:
Main Authors: | L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/873ea27afa2e4dde939b3d79061df97c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
by: L. V. Cherenova, et al.
Published: (2017) -
Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
by: Labib BA, et al.
Published: (2020) -
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
by: Adam Berg, et al.
Published: (2021) -
Coating with spermine-pullulan polymer enhances adenoviral transduction of mesenchymal stem cells
by: Wan L, et al.
Published: (2016) -
Identification of Adenovirus 7h Heterogeneity in the E3 Region
by: BRUZZONE,MARISOL, et al.
Published: (2001)